OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, August 28th IBOT, DMAT, GLCC, SEED, WEHI, CEGE

Our Stocks to Watch today include Industrial Biotechnology Corp. (OTC: IBOT), Dematco Inc. (OTCBB: DMAT), Good Life China Corp. (OTC: GLCC), Origin Agritech Ltd. (Nasdaq: SEED), WGL Entertainment Holdings Inc. (OTC: WEHI) and Cell Genesys Inc. (Nasdaq: CEGE).

INDUSTRIAL BIOTECHNOLOGY CORPORATION (OTC: IBOT)

"Up 4.46% in morning trading"

Company Profile:

Industrial Biotechnology Corporation, (IBC) provides products, services and technologies using renewable resources as an alternative to petroleum and traditional manufacturing methods. IBC production processes are eco-efficient and apply and adhere to sustainable practices and standards. IBC accomplishes this with the ALCHEMx Production Platforms™, which integrates technologies, sustainable manufacturing, and distribution with supply chain partners to meet customer needs and pricing requirements. IBC utilizes sugarcane based ethanol which is considered the leading cost efficient, energy balanced and environmentally sustainable feedstock source, when compared to petroleum and other alternative fuels.

DEMATCO INCORPORATED (OTCBB: DMAT)

"Up 43.33% in morning trading"

DeMatco, Inc. provides proprietary dematerialization services to the securities industry primarily in the United Kingdom. It converts financial instruments from paper form to electronic form so as to enable such instruments to be traded electronically on exchanges or exchange platforms on a peer to peer basis. The company was founded in 2005 and is based in Encino, California.

GOOD LIFE CHINA CORPORATION (OTC: GLCC)

"Up 20.00% in morning trading"

Good Life China Corporation operates a chain of franchised convenience stores in Hebei Province, the People’s Republic of China. The company employs retail concepts, such as e-commerce enabled POS/back office systems. It operates approximately 1,730 stores. The company also has an agreement with Petro China Beijing to provide distribution services and information management system services for the convenience stores in the gas stations belonging to Petro China Beijing Marketing Company. In addition, the company offers online sub prime financial services, such as money lending, forex trading, and advanced electronic funds management. Good Life China Corporation was incorporated in 1998 and is based in Toronto, Canada.

ORIGIN AGRITECH LIMITED (NASDAQ: SEED)

"Up 22.35% in morning trading"

Origin Agritech Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of hybrid crop seeds in the People's Republic of China. It primarily offers four products: corn, rice, cotton, and canola. The company also develops, produces, and sells both internally developed and licensed crop seeds. Origin Agritech distributes its products through a distribution network, including first-level distributors, second-level distributors, and retailers. It sells a majority of its seeds developed and produced under license agreements with the Corn Research Institute of Li County, Shijiazhuang Liyu Technology Development Co., Ltd., and the Henan Agricultural University. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

WGL ENTERTAINMENT HOLDINGS INCORPORATED (OTC: WEHI)

"Up slightly in morning trading"

WGL Entertainment Holdings, Inc., through its subsidiary WGL Entertainment, is the producer of the WGL Million Dollar Shootout Reality Television Series and several other made-for-TV sports entertainment events scheduled to be produced in 2008 and beyond.

CELL GENESYS INCORPORATED (NASDAQ: CEGE)

"Up 26.30% in morning trading"

Cell Genesys, Inc., a biotechnology company, engages in the development and commercialization of biological therapies for patients with cancer. It develops cell-based cancer immunotherapies and oncolytic virus therapies. The company's GVAX cancer Immunotherapies comprise Prostate Cancer, a phase III product for the treatment of prostate cancer; Pancreatic Cancer, a phase II product for pancreatic cancer; and Leukemia, a phase II product for the treatment of acute and chronic myelogenous leukemia, and myelodysplastic syndrome. Its Oncolytic Virus Therapy includes CG0070, a phase I product for the treatment of recurrent bladder cancer. Cell Genesys has alliance with Novartis AG for the development and commercialization of oncolytic virus therapies; research and development collaboration with Medarex, Inc.; and development and commercialization collaboration of GVAX immunotherapy with Takeda Pharmaceutical Company Limited for prostate cancer. The company was founded in 1988 and is headquartered in South San Francisco, California.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com is being compensated up to eight thousand dollars by a third party for IBOT advertising and promotional services.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.